Skip to main content
MSOX logo

AdvisorShares MSOS Daily Leveraged ETF (MSOX) Fund Overview

Educational signal · not a buy or sell recommendation · How to read this

$2.35 -$0.1245 (-5.03%)
Vol: 2.79M|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

AdvisorShares MSOS Daily Leveraged ETF (MSOX) trades at $2.35. AdvisorShares MSOS Daily Leveraged ETF (MSOX) is a financial services fund focused on providing leveraged investment results in the cannabis sector. Sector: Financials.

Price as of · Last analyzed: Mar 17, 2026
AdvisorShares MSOS Daily Leveraged ETF (MSOX) is a financial services fund focused on providing leveraged investment results in the cannabis sector. It primarily invests in equity securities of mid- and small-cap companies within the U.S. cannabis industry.

Analyst Coverage for MSOX: MSOX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the MSOX film Every key number, told as a short cinematic story — just press play. ~2 min

AdvisorShares MSOS Daily Leveraged ETF (MSOX) Financial Services Profile

IPO Year2022

AdvisorShares MSOS Daily Leveraged ETF (MSOX) leverages swap agreements to amplify returns relative to the US Cannabis ETF, focusing on mid- and small-cap equity securities in the rapidly evolving cannabis market.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for MSOX?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

The investment thesis for AdvisorShares MSOS Daily Leveraged ETF (MSOX) centers on its unique position within the cannabis sector, which is projected to grow significantly due to increasing legalization and consumer demand. The fund's leverage strategy aims to amplify returns, making it an attractive vehicle for investors looking to capitalize on this growth. Additionally, the fund's non-diversified nature allows for concentrated bets in high-potential stocks, which can lead to outsized gains. However, investors should be aware of the inherent risks associated with leveraged ETFs, including volatility and potential for significant losses in adverse market conditions. Overall, MSOX presents a compelling case for investors looking to gain exposure to the rapidly evolving cannabis market through a leveraged investment vehicle.

Based on FMP financials and quantitative analysis

MSOX Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Market cap of $0.02 billion reflects its niche focus within the cannabis sector.

  • Utilizes swap agreements to enhance exposure to the US Cannabis ETF, aiming for amplified returns.
  • Non-diversified fund allows for concentrated investments in high-potential mid- and small-cap cannabis stocks.
  • Beta of -0.62 indicates an inverse relationship to market movements, potentially appealing to risk-averse investors.
  • No dividend yield, aligning with its growth-focused investment strategy.

Who Are MSOX's Competitors?

MSOX is benchmarked below against 5 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
APRJ Innovator Premium Income 30 Barrier ETF $24.61 -0.10% $31.9M —
EGGY NestYield Dynamic Income ETF $35.26 -0.14% $30.9M —
EUO ProShares - UltraShort Euro $32.02 -0.34% $37.4M —
LRNZ TRUESHARES TECHNOLOGY, AI & DEEP LEARNING ETF $70.24 +0.98% $34.3M —
OZEM Roundhill Investments - GLP-1 & Weight Loss ETF $29.93 -0.85% $38.5M —

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are MSOX's Key Strengths?

Leveraged investment strategy can lead to higher returns in a growing market.

  • Focus on mid- and small-cap companies allows for capturing unique growth opportunities.
  • Non-diversified nature enables concentrated investments in high-potential stocks.

What Are MSOX's Weaknesses?

High volatility associated with leveraged ETFs can lead to significant losses.

  • Limited market cap may restrict growth potential compared to larger funds.
  • No dividend yield may deter income-focused investors.

What Are the Key Risks for MSOX?

Regulatory changes could affect the performance of cannabis investments.

  • High volatility in the cannabis market may lead to significant fluctuations in fund performance.
  • Competition from other funds may impact market share and investor interest.

What Are MSOX's Competitive Advantages?

  • Unique focus on mid- and small-cap cannabis companies differentiates MSOX from larger funds.
  • Leveraged investment strategy allows for amplified returns in a high-growth sector.
  • Non-diversified approach enables concentrated bets on high-potential stocks.

What Does MSOX Do?

AdvisorShares MSOS Daily Leveraged ETF (MSOX) was established to provide investors with leveraged exposure to the U.S. cannabis sector through economically-leveraged investment strategies. The fund primarily invests in equity securities, including common and preferred stocks, of mid- and small-capitalization companies, as well as utilizing total return swaps to enhance exposure to this burgeoning market. As a non-diversified fund, MSOX aims to capture the volatility and growth potential of the cannabis industry, which has seen significant interest from both retail and institutional investors. The fund's strategy is designed to produce returns that are multiples of the performance of the underlying US Cannabis ETF, thus appealing to investors looking for amplified exposure to this high-growth sector. MSOX's focus on mid- and small-cap companies allows it to tap into a diverse array of businesses within the cannabis space, ranging from cultivation to ancillary services. This strategic positioning is critical as the cannabis market continues to expand, driven by evolving regulatory landscapes and increasing consumer acceptance. With a market cap of $0.02 billion, MSOX operates within a niche segment of the asset management industry, catering specifically to investors seeking leveraged exposure to cannabis equities.

What Products and Services Does MSOX Offer?

  • Provide leveraged exposure to the U.S. cannabis sector through swap agreements.
  • Invest primarily in equity securities of mid- and small-cap cannabis companies.
  • Utilize total return swaps to enhance investment results relative to the US Cannabis ETF.
  • Focus on a non-diversified investment strategy to concentrate on high-potential stocks.
  • Aim to amplify returns for investors looking to capitalize on the cannabis market's growth.

How Does MSOX Make Money?

  • Generate returns through leveraged investments in cannabis-related equities.
  • Utilize swap agreements to achieve economically-leveraged investment results.
  • Focus on mid- and small-cap companies to capture higher growth potential.
  • Target investors seeking amplified exposure to the cannabis sector.

What Industry Does MSOX Operate In?

The asset management industry, particularly in the leveraged ETF segment, is witnessing a surge in interest due to the rapid growth of the cannabis market. With increasing legalization across various states and countries, the cannabis sector is projected to expand significantly, presenting opportunities for specialized funds like MSOX. The competitive landscape includes other leveraged ETFs and traditional funds that invest in cannabis, but MSOX's unique focus on mid- and small-cap companies differentiates it. The overall cannabis market is expected to grow at a CAGR of 14% from 2021 to 2028, providing a robust backdrop for MSOX's investment strategy.

Who Are MSOX's Key Customers?

  • Retail investors looking for leveraged exposure to the cannabis market.
  • Institutional investors interested in niche investment strategies.
  • Wealth management firms seeking diversified portfolios with high-growth potential.
Model self-rating on this text: 65% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● Price is current
  • ● No filing on record
  • ● No analyst coverage
  • ● This is an etf, not an operating company

MSOX Financials

Bull Case vs Bear Case

Bull Case

  • Leveraged investment strategy can lead to higher returns in a growing market.
  • Focus on mid- and small-cap companies allows for capturing unique growth opportunities.
  • Non-diversified nature enables concentrated investments in high-potential stocks.
  • Upcoming: Continued legalization of cannabis in various U.S. states may drive market growth.

Bear Case

  • High volatility associated with leveraged ETFs can lead to significant losses.
  • Limited market cap may restrict growth potential compared to larger funds.
  • No dividend yield may deter income-focused investors.
  • Potential: Regulatory changes could affect the performance of cannabis investments.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

MSOX Latest News

No recent news available for MSOX.

MSOX Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MSOX.

Price Targets

Wall Street price target analysis for MSOX.

MSOX MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MSOX; grades run from A+ (80-100) to F (below 30).

What Investors Ask About AdvisorShares MSOS Daily Leveraged ETF (MSOX) — Financials

What does AdvisorShares MSOS Daily Leveraged ETF do?

AdvisorShares MSOS Daily Leveraged ETF (MSOX) provides leveraged exposure to the U.S. cannabis sector through swap agreements. The fund primarily invests in equity securities of mid- and small-cap companies within the cannabis industry, aiming to amplify returns relative to the US Cannabis ETF.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis